Eluvixtamab Antibody
Eluvixtamab (AMG-330) is a CD33/CD3-targeting bispecific T-cell engager (BiTE) for research. It directs T-cell cytotoxicity against CD33+ AML cells by binding a linear epitope (core: IPYYDKN) in the CD33 V-set domain, facilitating their elimination in vitro and in vivo models.
Product Specifications
Target
Integrin
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog